Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck & Co., Inc. : Buyers are coming back

03/29/2021 | 04:43am EDT
long trade
Stop-loss triggered
Entry price : 77.32$ | Target : 83.5$ | Stop-loss : 74.89$ | Potential : 7.99%
The return of higher trading volumes and volatility could reflect theoretically the starting point of the return of a new upward move for shares in Merck & Co., Inc.. The upward movement can be expected to continue.
Investors have an opportunity to buy the stock and target the $ 83.5.
Merck & Co., Inc. : Merck & Co., Inc. : Buyers are coming back
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • With a P/E ratio at 13.73 for the current year and 12.34 for next year, earnings multiples are highly attractive compared with competitors.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

  • Stock prices approach a strong long-term resistance in weekly data at USD 78.78.
  • The group usually releases earnings worse than estimated.
  • The underlying tendency is negative on the weekly chart below the resistance at 78.78 USD

© MarketScreener.com 2021

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2021 46 932 M - -
Net income 2021 12 744 M - -
Net Debt 2021 12 127 M - -
P/E ratio 2021 17,4x
Yield 2021 3,35%
Capitalization 195 B 195 B -
EV / Sales 2021 4,41x
EV / Sales 2022 4,00x
Nbr of Employees 73 500
Free-Float 70,7%
Upcoming event on MERCK & CO., INC.
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 76,87 $
Average target price 94,45 $
Spread / Average Target 22,9%
EPS Revisions
Managers and Directors
Robert M. Davis President, Chief Executive Officer & Director
Caroline A. Litchfield Chief Financial Officer & Executive Vice President
Kenneth C. Frazier Executive Chairman
Sandy Tremps Vice President-R&D IT CIO
Dave Williams Chief Information & Digital Officer
Sector and Competitors
1st jan.Capi. (M$)
MERCK & CO., INC.-6.03%194 639
JOHNSON & JOHNSON9.42%453 313
ROCHE HOLDING AG13.38%337 105
PFIZER, INC.16.30%239 637
NOVARTIS AG0.28%225 343